{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:17:01Z","timestamp":1792459021254,"version":"4.5.0"},"reference-count":144,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pheochromocytomas and sympathetic paraganglioma (PPGL) are rare chromaffin cell tumors originating in the adrenal medulla and sympathetic paraganglia, respectively, which share the capacity to synthesize and release catecholamines. The incidence of PPGL has increased in recent years. Surgical resection is the only curative treatment for PPGL. Management of patients with PPGL is complex and should be done by a specialized multidisciplinary team in centers with broad expertise. Surgical resection of a PPGL is a high-risk procedure for which optimal pretreatment with antihypertensive drugs is required in combination with state-of-the-art surgical procedures and anesthesiological techniques. In this article we discuss the underlying evidence and the pros and cons of presurgical medical preparation. Finally, the areas of uncertainty and controversies in this field are addressed.<\/jats:p>","DOI":"10.1210\/clinem\/dgaa441","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T18:34:17Z","timestamp":1594146857000},"page":"3088-3102","source":"Crossref","is-referenced-by-count":55,"title":["Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma"],"prefix":"10.1210","volume":"105","author":[{"given":"Annika M A","family":"Berends","sequence":"first","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel N","family":"Kerstens","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W M","family":"Lenders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Department of Medicine III, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-5748","authenticated-orcid":false,"given":"Henri J L M","family":"Timmers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"2020102702204456700_CIT0001","volume-title":"WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organ","author":"Loyd","year":"2017","edition":"4"},{"issue":"1","key":"2020102702204456700_CIT0002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12105-017-0786-1","article-title":"Update from the 4th edition of the World Health Organization classification of head and neck tumours: paragangliomas","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol."},{"key":"2020102702204456700_CIT0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med."},{"key":"2020102702204456700_CIT0004","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"2020102702204456700_CIT0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: Learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"2020102702204456700_CIT0006","doi-asserted-by":"crossref","first-page":"e86756","DOI":"10.1371\/journal.pone.0086756","article-title":"Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours","volume":"9","author":"Crona","year":"2014","journal-title":"Plos One."},{"issue":"1","key":"2020102702204456700_CIT0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CCO.0000000000000249","article-title":"Pheochromocytoma and paraganglioma: molecular testing and personalized medicine","volume":"28","author":"Burnichon","year":"2016","journal-title":"Curr Opin Oncol."},{"key":"2020102702204456700_CIT0008","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol."},{"key":"2020102702204456700_CIT0009","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cancers11081070","article-title":"Pheochromocytomas and paragangliomas: new developments with regard to classification, genetics, and cell of origin","volume":"11","author":"Koopman","year":"2019","journal-title":"Cancers (Basel)."},{"key":"2020102702204456700_CIT0010","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1001\/jama.2012.5960","article-title":"Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996\u20132010","volume":"307","author":"Smith-Bindman","year":"2012","journal-title":"JAMA."},{"key":"2020102702204456700_CIT0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammer","year":"2018","journal-title":"Endocr Connect."},{"key":"2020102702204456700_CIT0012","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2018-01707","article-title":"Pheochromocytoma characteristics and behavior differ depending on method of discovery","volume":"104","author":"Gruber","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2020102702204456700_CIT0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-19-0159","article-title":"Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion","volume":"181","author":"Geroula","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2020102702204456700_CIT0014","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: european society of endocrinology clinical practice guideline in collaboration with the European Network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2020102702204456700_CIT0015","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"2020102702204456700_CIT0016","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1022981801344","article-title":"Pheochromoocytoma as an endocrine emergency","volume":"4","author":"Brouwers","year":"2003","journal-title":"Rev Endocr Metab Disord."},{"issue":"1","key":"2020102702204456700_CIT0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.12324","article-title":"Phaeochromocytoma [corrected] crisis","volume":"80","author":"Whitelaw","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"19","key":"2020102702204456700_CIT0018","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/heartjnl-2013-304073","article-title":"Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma","volume":"99","author":"Giavarini","year":"2013","journal-title":"Heart."},{"key":"2020102702204456700_CIT0019","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/EJE-15-0483","article-title":"Life-threatening events in patients with pheochromcytoma","volume":"173","author":"Reister","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2020102702204456700_CIT0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CRD.0000000000000141","article-title":"Cardiovascular Manifestations of Pheochromocytoma","volume":"25","author":"Gu","year":"2017","journal-title":"Cardiol Rev."},{"key":"2020102702204456700_CIT0021","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/01.RES.34.6.812","article-title":"Effects of norepinephrine on coronary circulation and left ventricular dynamics in the conscious dog","volume":"34","author":"Vatner","year":"1974","journal-title":"Circ Res."},{"issue":"4","key":"2020102702204456700_CIT0022","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.RES.67.4.1027","article-title":"Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via beta 1-adrenoceptor activation","volume":"67","author":"Pettersson","year":"1990","journal-title":"Circ Res."},{"key":"2020102702204456700_CIT0023","doi-asserted-by":"crossref","first-page":"III75","DOI":"10.1161\/01.HYP.17.4_Suppl.III75","article-title":"Sympathetic drive and vascular damage in hypertension and atherosclerosis","volume":"17","author":"Pauletto","year":"1991","journal-title":"Hypertension."},{"key":"2020102702204456700_CIT0024","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1139\/Y09-042","article-title":"Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress induced heart disease","volume":"87","author":"Adameova","year":"2009","journal-title":"Can J Physiol Pharmacol."},{"key":"2020102702204456700_CIT0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1472-8206.2010.00836.x","article-title":"Role of catecholamine oxidation in sudden cardiac death","volume":"24","author":"Dhalla","year":"2010","journal-title":"Fundam Clin Pharmacol."},{"key":"2020102702204456700_CIT0026","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the european society of hypertension","author":"Lenders","year":"2020","journal-title":"J Hypertens."},{"key":"2020102702204456700_CIT0027","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Taieb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"6","key":"2020102702204456700_CIT0028","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2020102702204456700_CIT0029","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1007\/s00464-013-3169-z","article-title":"Society of gastrointestinal and endoscopic surgeons. SAGES guidelines for minimally invasive treatment of adrenal pathology","volume":"27","author":"Stefanidis","year":"2013","journal-title":"Surg Endosc."},{"key":"2020102702204456700_CIT0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.02.009","article-title":"Laparoscopic adrenalectomy (LA) vs. open adrenalectomy (OA) for pheochromocytoma (PHEO): a systematic review and meta-analysis","author":"Li","year":"2020","journal-title":"Eur J Surg Oncol."},{"key":"2020102702204456700_CIT0031","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/SLA.0000000000000982","article-title":"Randomized clinical trial of posterior retroperitoneoscopic adrenalectomy versus lateral transperitoneal laparoscopic adrenalectomy with a 5-year follow-up","volume":"260","author":"Barczy\u0144ski","year":"2014","journal-title":"Ann Surg."},{"issue":"5","key":"2020102702204456700_CIT0032","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/SLA.0000000000002603","article-title":"Lateral transperitoneal adrenalectomy versus posterior retroperitoneoscopic adrenalectomy for benign adrenal gland disease: randomized controlled trial at a single tertiary medical center","volume":"269","author":"Chai","year":"2019","journal-title":"Ann Surg."},{"key":"2020102702204456700_CIT0033","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jss.2019.05.042","article-title":"Conversion during laparoscopic adrenalectomy for pheochromocytoma: a cohort study in 244 patients","volume":"243","author":"Schweitzer","year":"2019","journal-title":"J Surg Res."},{"issue":"5","key":"2020102702204456700_CIT0034","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00268-005-0373-6","article-title":"Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients","volume":"30","author":"Walz","year":"2006","journal-title":"World J Surg."},{"issue":"4","key":"2020102702204456700_CIT0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13304-017-0459-3","article-title":"Abdominal paragangliomas: a quantitative prognostic score as predictive factor of the feasibility of the laparoscopic approach","volume":"69","author":"Alemanno","year":"2017","journal-title":"Updates Surg."},{"key":"2020102702204456700_CIT0036","doi-asserted-by":"crossref","first-page":"e198898","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs. cortical-sparing adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open."},{"issue":"5","key":"2020102702204456700_CIT0037","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archsurg.1951.01250030644004","article-title":"Pheochromocytoma. Anesthetic management during surgical treatment","volume":"62","author":"APGAR","year":"1951","journal-title":"AMA Arch Surg."},{"key":"2020102702204456700_CIT0038","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00000658-196306000-00017","article-title":"Experience with pheochromocytoma in 21 patients: use of dichloroisoproterenol hydrochloride for cardiac arrhythmia","volume":"157","author":"Riddell","year":"1963","journal-title":"Ann Surg."},{"issue":"3","key":"2020102702204456700_CIT0039","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/jcan.2002.124150","article-title":"Perioperative management of pheochromocytoma","volume":"16","author":"Kinney","year":"2002","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"13","key":"2020102702204456700_CIT0040","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1245\/s10434-015-4519-y","article-title":"Hemodynamic stability during pheochromocytoma resection: lessons learned over the last two decades","volume":"22","author":"Livingstone","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"2020102702204456700_CIT0041","article-title":"Efficacy of \u03b1-blockers on hemodynamic control during pheochromocytoma resection - a randomized controlled trial","author":"Buitenwerf","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2020102702204456700_CIT0042","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1053\/j.jvca.2017.02.023","article-title":"Perioperative management of pheochromocytoma","volume":"31","author":"Naranjo","year":"2017","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"16","key":"2020102702204456700_CIT0043","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.1949.82900510003006a","article-title":"Treatment of a patient with a pheochromocytoma; use of an adrenolytic drug before and during operation","volume":"140","author":"GRIMSON","year":"1949","journal-title":"J Am Med Assoc."},{"key":"2020102702204456700_CIT0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"Manger","year":"2006","journal-title":"Ann N Y Acad Sci."},{"issue":"11","key":"2020102702204456700_CIT0045","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020102702204456700_CIT0046","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2009-1051","article-title":"Risk factors for hemodynamic instability during surgery for pheochromocytoma","volume":"95","author":"Bruynzeel","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"6 Pt 2","key":"2020102702204456700_CIT0047","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/0002-8703(88)90230-X","article-title":"Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma","volume":"116","author":"Miura","year":"1988","journal-title":"Am Heart J."},{"issue":"3","key":"2020102702204456700_CIT0048","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00268-013-2325-x","article-title":"Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin","volume":"38","author":"Agrawal","year":"2014","journal-title":"World J Surg."},{"issue":"2","key":"2020102702204456700_CIT0049","doi-asserted-by":"crossref","first-page":"508.e6","DOI":"10.1016\/j.urology.2010.03.032","article-title":"Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma","volume":"76","author":"Weingarten","year":"2010","journal-title":"Urology."},{"issue":"8","key":"2020102702204456700_CIT0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","article-title":"Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma","volume":"26","author":"Prys-Roberts","year":"2002","journal-title":"World J Surg."},{"issue":"3","key":"2020102702204456700_CIT0051","first-page":"191","article-title":"Alpha blockade in preoperative preparation of patients with pheochromocytomas","volume":"87","author":"Kocak","year":"2002","journal-title":"Int Surg."},{"issue":"2","key":"2020102702204456700_CIT0052","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12020-010-9381-x","article-title":"Selective \u03b11-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma","volume":"38","author":"Zhu","year":"2010","journal-title":"Endocrine."},{"issue":"2","key":"2020102702204456700_CIT0053","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-198121020-00001","article-title":"alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use","volume":"21","author":"Brogden","year":"1981","journal-title":"Drugs."},{"issue":"8","key":"2020102702204456700_CIT0054","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","article-title":"Metyrosine and pheochromocytoma","volume":"157","author":"Steinsapir","year":"1997","journal-title":"Arch Intern Med."},{"key":"2020102702204456700_CIT0055","doi-asserted-by":"crossref","first-page":"S646","DOI":"10.1245\/s10434-015-4862-z","article-title":"Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma","volume":"22 Suppl 3","author":"Wachtel","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"2020102702204456700_CIT0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijsu.2017.08.026","article-title":"Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma","volume":"46","author":"Butz","year":"2017","journal-title":"Int J Surg."},{"issue":"11","key":"2020102702204456700_CIT0057","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/archinte.1985.00360110190038","article-title":"Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma","volume":"145","author":"Ram","year":"1985","journal-title":"Arch Intern Med."},{"issue":"12","key":"2020102702204456700_CIT0058","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s12630-015-0480-2","article-title":"Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report","volume":"62","author":"Thanapaalasingham","year":"2015","journal-title":"Can J Anaesth."},{"issue":"3","key":"2020102702204456700_CIT0059","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI105754","article-title":"Biochemical and pharmacologic effects of alpha-methyltyrosine in man","volume":"47","author":"Engelman","year":"1968","journal-title":"J Clin Invest."},{"issue":"6","key":"2020102702204456700_CIT0060","first-page":"1149","article-title":"Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients","volume":"106","author":"Proye","year":"1989","journal-title":"Surgery."},{"issue":"5","key":"2020102702204456700_CIT0061","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","article-title":"The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas","volume":"60","author":"Lebuffe","year":"2005","journal-title":"Anaesthesia."},{"issue":"6","key":"2020102702204456700_CIT0062","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.surg.2014.08.022","article-title":"Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma","volume":"156","author":"Brunaud","year":"2014","journal-title":"Surgery."},{"issue":"2","key":"2020102702204456700_CIT0063","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2265.2006.02571.x","article-title":"Phaeochromocytomas presenting as acute crises after beta blockade therapy","volume":"65","author":"Sibal","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"8072","key":"2020102702204456700_CIT0064","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(78)90772-9","article-title":"Hypertensive response to labetalol in phaeochromocytoma","volume":"1","author":"Briggs","year":"1978","journal-title":"Lancet."},{"issue":"6236","key":"2020102702204456700_CIT0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmj.281.6236.387-a","article-title":"Hypertensive response to labetalol in phaeochromocytoma","volume":"281","author":"Feek","year":"1980","journal-title":"Br Med J."},{"issue":"10","key":"2020102702204456700_CIT0066","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/bja\/56.10.1179","article-title":"Labetalol and phaeochromocytoma","volume":"56","author":"Navaratnarajah","year":"1984","journal-title":"Br J Anaesth."},{"issue":"4","key":"2020102702204456700_CIT0067","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/j.1875-9114.1983.tb03252.x","article-title":"Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects","volume":"3","author":"MacCarthy","year":"1983","journal-title":"Pharmacotherapy."},{"key":"2020102702204456700_CIT0068","first-page":"290","article-title":"Preoperative pharmacological management of phaeochromocytoma","volume":"64","author":"der Horst-Schrivers","year":"2006","journal-title":"Neth J Med."},{"key":"2020102702204456700_CIT0069","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM196002252620805","article-title":"Pheochromocytoma: postoperative shock and blood volume","volume":"262","author":"Brunjes","year":"1960","journal-title":"N Engl J Med."},{"issue":"6","key":"2020102702204456700_CIT0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-5347(17)60053-3","article-title":"Preoperative blood transfusion in the safe surgical management of pheochromocytoma: a review of 46 cases","volume":"111","author":"Deoreo","year":"1974","journal-title":"J Urol."},{"issue":"10","key":"2020102702204456700_CIT0071","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/bja\/49.10.991","article-title":"Anaesthetic management of patients with phaeochromocytoma. A review of 102 cases","volume":"49","author":"Desmonts","year":"1977","journal-title":"Br J Anaesth."},{"issue":"1","key":"2020102702204456700_CIT0072","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00464-019-06777-z","article-title":"The determination of real fluid requirements in laparoscopic resection of pheochromocytoma using minimally invasive hemodynamic monitoring: a prospectively designed trial","volume":"34","author":"Niederle","year":"2020","journal-title":"Surg Endosc."},{"issue":"11","key":"2020102702204456700_CIT0073","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2165\/00002018-200730110-00004","article-title":"Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management","volume":"30","author":"Eisenhofer","year":"2007","journal-title":"Drug Saf."},{"issue":"5","key":"2020102702204456700_CIT0074","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/cen.12813","article-title":"Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review","volume":"83","author":"Barrett","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2020102702204456700_CIT0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2012-3020","article-title":"Pheochromocytoma crisis is not a surgical emergency","volume":"98","author":"Scholten","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2020102702204456700_CIT0076","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12020-013-0007-y","article-title":"Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features","volume":"45","author":"Mazza","year":"2014","journal-title":"Endocrine."},{"issue":"1","key":"2020102702204456700_CIT0077","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00129784-200303010-00003","article-title":"Hypertensive emergencies. Etiology and management","volume":"3","author":"Tuncel","year":"2003","journal-title":"Am J Cardiovasc Drugs."},{"issue":"3","key":"2020102702204456700_CIT0078","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.pop.2008.05.001","article-title":"Hypertensive crises","volume":"35","author":"Hebert","year":"2008","journal-title":"Prim Care."},{"issue":"3","key":"2020102702204456700_CIT0079","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.jvca.2012.01.002","article-title":"Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin","volume":"26","author":"Lord","year":"2012","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"2020102702204456700_CIT0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/bjaed\/mkv033","article-title":"Perioperative care of phaeochromocytoma","volume":"16","author":"Connor","year":"2016","journal-title":"BJA Educ."},{"issue":"3","key":"2020102702204456700_CIT0081","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1213\/01.ANE.0000133136.01381.52","article-title":"Pheochromocytoma crisis: the use of magnesium sulfate","volume":"99","author":"James","year":"2004","journal-title":"Anesth Analg."},{"issue":"6","key":"2020102702204456700_CIT0082","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0888-6296(87)90042-1","article-title":"Continuous intravenous infusions of phentolamine and esmolol for preoperative and intraoperative adrenergic blockade in patients with pheochromocytoma","volume":"1","author":"Gabrielson","year":"1987","journal-title":"J Cardiothorac Anesth."},{"issue":"2","key":"2020102702204456700_CIT0083","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2146\/ajhp090619","article-title":"Phentolamine continuous infusion in a patient with pheochromocytoma","volume":"68","author":"McMillian","year":"2011","journal-title":"Am J Health Syst Pharm."},{"issue":"2","key":"2020102702204456700_CIT0084","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin Pharmacokinet."},{"key":"2020102702204456700_CIT0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03256583","article-title":"Clevidipine: a review of its use in the management of acute hypertension","volume":"9","author":"Deeks","year":"2009","journal-title":"Am J Cardiovasc Drugs."},{"issue":"5","key":"2020102702204456700_CIT0086","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00268-013-1933-9","article-title":"Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method","volume":"37","author":"Habbe","year":"2013","journal-title":"World J Surg."},{"issue":"9","key":"2020102702204456700_CIT0087","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/jhh.2008.172","article-title":"Preparation for surgery of phaeochromocytoma by blockade of alpha-adrenergic receptors with urapidil: what dose?","volume":"23","author":"Gosse","year":"2009","journal-title":"J Hum Hypertens."},{"issue":"4","key":"2020102702204456700_CIT0088","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0970-9185.142799","article-title":"Sodium nitroprusside in 2014: a clinical concepts review","volume":"30","author":"Hottinger","year":"2014","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"2020102702204456700_CIT0089","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/bja\/62.6.616","article-title":"Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics","volume":"62","author":"James","year":"1989","journal-title":"Br J Anaesth."},{"issue":"4","key":"2020102702204456700_CIT0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/ALN.0b013e318210483d","article-title":"Magnesium\u2013essentials for anesthesiologists","volume":"114","author":"Herroeder","year":"2011","journal-title":"Anesthesiology."},{"issue":"6","key":"2020102702204456700_CIT0091","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejcts.2006.09.003","article-title":"Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery","volume":"30","author":"Dunning","year":"2006","journal-title":"Eur J Cardiothorac Surg."},{"issue":"9","key":"2020102702204456700_CIT0092","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/europace\/eul108","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"8","author":"Zipes","year":"2006","journal-title":"Europace."},{"issue":"3","key":"2020102702204456700_CIT0093","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00000542-199309000-00006","article-title":"Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers. A comparison with isoflurane","volume":"79","author":"Ebert","year":"1993","journal-title":"Anesthesiology."},{"issue":"3","key":"2020102702204456700_CIT0094","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/0970-9185.161665","article-title":"Pheochromocytoma resection: Current concepts in anesthetic management","volume":"31","author":"Ramakrishna","year":"2015","journal-title":"J Anaesthesiol Clin Pharmacol."},{"issue":"12","key":"2020102702204456700_CIT0095","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bja\/58.12.1453","article-title":"Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management","volume":"58","author":"Hull","year":"1986","journal-title":"Br J Anaesth."},{"issue":"1","key":"2020102702204456700_CIT0096","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1213\/00000539-199901000-00004","article-title":"Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma","volume":"88","author":"Joris","year":"1999","journal-title":"Anesth Analg."},{"issue":"5","key":"2020102702204456700_CIT0097","first-page":"1118","article-title":"Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection","volume":"91","author":"Kinney","year":"2000","journal-title":"Anesth Analg."},{"issue":"1","key":"2020102702204456700_CIT0098","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1213\/00000539-197701000-00016","article-title":"Enflurane anesthesia for surgical removal of pheochromocytoma","volume":"56","author":"Janeczko","year":"1977","journal-title":"Anesth Analg."},{"key":"2020102702204456700_CIT0099","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000542-196509000-00022","article-title":"Halothane anesthesia and catecholamine levels in a patient with pheochromocytoma","volume":"26","author":"ETSTEN","year":"1965","journal-title":"Anesthesiology."},{"issue":"4","key":"2020102702204456700_CIT0100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000542-198310000-00009","article-title":"Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog","volume":"59","author":"Maze","year":"1983","journal-title":"Anesthesiology."},{"issue":"6","key":"2020102702204456700_CIT0101","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/bja\/72.6.707","article-title":"Use of desflurane during resection of phaeochromocytoma","volume":"72","author":"Lippmann","year":"1994","journal-title":"Br J Anaesth."},{"issue":"5","key":"2020102702204456700_CIT0102","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/j.jvca.2004.07.015","article-title":"Desflurane and remifentanil use during resection of a cardiac pheochromocytoma","volume":"18","author":"Ng","year":"2004","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"1","key":"2020102702204456700_CIT0103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40981-018-0212-z","article-title":"Use of desflurane during anesthesia for resection of extra-adrenal pheochromocytoma: a case report","volume":"4","author":"Oda","year":"2018","journal-title":"JA Clin Rep."},{"issue":"3","key":"2020102702204456700_CIT0104","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-6576.1991.tb03287.x","article-title":"Propofol-fentanyl anesthesia for pheochromocytoma resection","volume":"35","author":"Strebel","year":"1991","journal-title":"Acta Anaesthesiol Scand."},{"issue":"3","key":"2020102702204456700_CIT0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-6576.2009.02120.x","article-title":"Dexmedetomidine infusion during surgery in patients with a pheochromocytoma","volume":"54","author":"Schumann","year":"2010","journal-title":"Acta Anaesthesiol Scand."},{"issue":"2","key":"2020102702204456700_CIT0106","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007611-198202000-00022","article-title":"Pharmacologic agents in the management of pheochromocytoma","volume":"75","author":"Juan","year":"1982","journal-title":"South Med J."},{"issue":"1","key":"2020102702204456700_CIT0107","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0750-7658(05)80276-X","article-title":"[Anesthesia for cesarean section and excision of pheochromocytoma caused by Sipple\u2019s syndrome]","volume":"10","author":"Palot","year":"1991","journal-title":"Ann Fr Anesth Reanim."},{"issue":"8","key":"2020102702204456700_CIT0108","first-page":"595","article-title":"Pediatric pheochromocytoma. A 36-year review","volume":"12","author":"Ein","year":"1997","journal-title":"Pediatr Surg Int."},{"issue":"5","key":"2020102702204456700_CIT0109","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5152\/TJAR.2018.44442","article-title":"Propofol versus thiopental for rapid-sequence induction in isolated systolic hypertensive patients: a factorial randomized double-blind clinical trial","volume":"46","author":"Aslan","year":"2018","journal-title":"Turk J Anaesthesiol Reanim."},{"issue":"5","key":"2020102702204456700_CIT0110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/bja\/75.5.588","article-title":"Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine","volume":"75","author":"Naguib","year":"1995","journal-title":"Br J Anaesth."},{"issue":"6","key":"2020102702204456700_CIT0111","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00000542-198155060-00017","article-title":"ORG NC45 (Norcuron) and pheochromocytoma: a report of three cases","volume":"55","author":"Gencarelli","year":"1981","journal-title":"Anesthesiology."},{"issue":"6","key":"2020102702204456700_CIT0112","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00000542-196811000-00025","article-title":"Cardiac arrhythmias associated with succinylcholine in a patient with pheochromocytoma","volume":"29","author":"Stoner","year":"1968","journal-title":"Anesthesiology."},{"issue":"7","key":"2020102702204456700_CIT0113","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2044.1976.tb11907.x","article-title":"Anaesthesia in patients with phaeochromocytoma","volume":"31","author":"Stamenkovi\u0107","year":"1976","journal-title":"Anaesthesia."},{"issue":"2","key":"2020102702204456700_CIT0114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1399-6576.1973.tb00802.x","article-title":"Blood catecholamine changes after pancuronium","volume":"17","author":"Nana","year":"1973","journal-title":"Acta Anaesthesiol Scand."},{"issue":"4","key":"2020102702204456700_CIT0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF03007810","article-title":"Severe hypertension associated with pancuronium in a patient with a phaeochromocytoma","volume":"28","author":"Jones","year":"1981","journal-title":"Can Anaesth Soc J."},{"issue":"2","key":"2020102702204456700_CIT0116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2044.1967.tb02731.x","article-title":"Phaeochromocytoma, neurofibromatosis and pregnancy","volume":"22","author":"Humble","year":"1967","journal-title":"Anaesthesia."},{"issue":"11","key":"2020102702204456700_CIT0117","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1213\/00000539-198811000-00025","article-title":"Atracurium and pheochromocytoma: a report of three cases","volume":"67","author":"Amaranath","year":"1988","journal-title":"Anesth Analg."},{"issue":"8","key":"2020102702204456700_CIT0118","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1213\/00000539-198708000-00005","article-title":"Histamine release by four narcotics: a double-blind study in humans","volume":"66","author":"Flacke","year":"1987","journal-title":"Anesth Analg."},{"issue":"1","key":"2020102702204456700_CIT0119","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/bja\/85.1.44","article-title":"Phaeochromocytoma\u2013recent progress in its management","volume":"85","author":"Prys-Roberts","year":"2000","journal-title":"Br J Anaesth."},{"issue":"4","key":"2020102702204456700_CIT0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2044.2003.03080.x","article-title":"The use of remifentanil in the anaesthetic management of patients undergoing adrenalectomy: a report of three cases","volume":"58","author":"Breslin","year":"2003","journal-title":"Anaesthesia."},{"issue":"1","key":"2020102702204456700_CIT0121","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5152\/TJAR.2016.25993","article-title":"Perioperative management of severe hypertension during laparoscopic surgery for pheochromocytoma","volume":"44","author":"Erdo\u011fan","year":"2016","journal-title":"Turk J Anaesthesiol Reanim."},{"issue":"2","key":"2020102702204456700_CIT0122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000542-198202000-00003","article-title":"Histamine release during morphine and fentanyl anesthesia","volume":"56","author":"Rosow","year":"1982","journal-title":"Anesthesiology."},{"issue":"3","key":"2020102702204456700_CIT0123","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpainsymman.2007.11.002","article-title":"Pain and nausea in malignant pheochromocytoma: a pharmacological minefield","volume":"35","author":"Koh","year":"2008","journal-title":"J Pain Symptom Manage."},{"issue":"5","key":"2020102702204456700_CIT0124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000542-197705000-00014","article-title":"The pressor effect of droperidol on a patient with pheochromocytoma","volume":"46","author":"Sumikawa","year":"1977","journal-title":"Anesthesiology."},{"issue":"4","key":"2020102702204456700_CIT0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00000542-197904000-00019","article-title":"Innovar-induced hypertensive crises in patients with pheochromocytoma","volume":"50","author":"Bittar","year":"1979","journal-title":"Anesthesiology."},{"key":"2020102702204456700_CIT0126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000542-198501000-00004","article-title":"Mechanism of the effect of droperidol to induce catecholamine efflux from the adrenal medulla","volume":"62","author":"Sumikawa","year":"1985","journal-title":"Anesthesiology."},{"key":"2020102702204456700_CIT0127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/ERC-08-0190","article-title":"Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors","volume":"16","author":"Guillemot","year":"2009","journal-title":"Endocr Relat Cancer."},{"issue":"5","key":"2020102702204456700_CIT0128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1440-1681.1992.tb00453.x","article-title":"Effects of repeated doses of pseudoephedrine on blood pressure and plasma catecholamines in normal subjects and in patients with phaeochromocytoma","volume":"19","author":"Gordon","year":"1992","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"12","key":"2020102702204456700_CIT0129","first-page":"1391","article-title":"[Lessons learned from anesthetic management of pheochromocytoma resection: a report of three cases]","volume":"53","author":"Chang","year":"2004","journal-title":"Masui."},{"issue":"7","key":"2020102702204456700_CIT0130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3949\/ccjm.57.7.613","article-title":"Perioperative management of 63 patients with pheochromocytoma","volume":"57","author":"Boutros","year":"1990","journal-title":"Cleve Clin J Med."},{"issue":"6","key":"2020102702204456700_CIT0131","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.surg.2014.08.020","article-title":"Hypoglycemia after resection of pheochromocytoma","volume":"156","author":"Chen","year":"2014","journal-title":"Surgery."},{"issue":"2","key":"2020102702204456700_CIT0132","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/iju.13864","article-title":"Incidence and predictive factors of hypoglycemia after pheochromocytoma resection","volume":"26","author":"Araki","year":"2019","journal-title":"Int J Urol."},{"issue":"9 Suppl","key":"2020102702204456700_CIT0133","doi-asserted-by":"crossref","first-page":"S508","DOI":"10.1097\/01.CCM.0000278047.06965.20","article-title":"Glucose metabolism and catecholamines","volume":"35","author":"Barth","year":"2007","journal-title":"Crit Care Med."},{"key":"2020102702204456700_CIT0134","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00210-003-0858-5","article-title":"Involvement of alpha1 and beta-adrenoreceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell","volume":"369","author":"Vieira","year":"2004","journal-title":"Arch Pharmacol."},{"issue":"3","key":"2020102702204456700_CIT0135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(01)61762-2","article-title":"Successful outcomes in pheochromocytoma surgery in the modern era","volume":"161","author":"Ulchaker","year":"1999","journal-title":"J Urol."},{"issue":"2","key":"2020102702204456700_CIT0136","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bja\/aew392","article-title":"Perioperative \u03b1-receptor blockade in phaeochromocytoma surgery: an observational case series","volume":"118","author":"Groeben","year":"2017","journal-title":"Br J Anaesth."},{"issue":"2","key":"2020102702204456700_CIT0137","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1002\/bjs.11378","article-title":"International multicentre review of perioperative management and outcome for catecholamine-producing tumours","volume":"107","author":"Groeben","year":"2020","journal-title":"Br J Surg."},{"key":"2020102702204456700_CIT0138","doi-asserted-by":"crossref","DOI":"10.1007\/s00464-020-07439-1","article-title":"Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience","author":"Buisset","year":"2020","journal-title":"Surg Endosc."},{"issue":"2","key":"2020102702204456700_CIT0139","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00540-018-2447-2","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass","volume":"32","author":"Yamazaki","year":"2018","journal-title":"J Anesth."},{"issue":"6","key":"2020102702204456700_CIT0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0000000000002220","article-title":"Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study","volume":"267","author":"Shin","year":"2018","journal-title":"Ann Surg."},{"issue":"4","key":"2020102702204456700_CIT0141","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/EJA.0000000000000941","article-title":"The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability","volume":"36","author":"Buitenwerf","year":"2019","journal-title":"Eur J Anaesthesiol."},{"issue":"1","key":"2020102702204456700_CIT0142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-11-0148","article-title":"Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients","volume":"165","author":"Scholten","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2020102702204456700_CIT0143","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/jc.2014-2998","article-title":"Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas","volume":"100","author":"Lafont","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2020102702204456700_CIT0144","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/EJA.0000000000000844","article-title":"The role of pre-operative \u03b1-blockade in patients with normotensive phaeochromocytoma or paraganglioma: A retrospective cohort study","volume":"35","author":"Kong","year":"2018","journal-title":"Eur J Anaesthesiol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa441\/33472131\/dgaa441.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/105\/9\/3088\/34037448\/dgaa441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/105\/9\/3088\/34037448\/dgaa441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T16:57:57Z","timestamp":1667321877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/9\/3088\/5868468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":144,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa441","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,7,7]]}}}